表紙
市場調查報告書

動脈封閉設備:醫療設備的開發平台評估

Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 333945
出版日期 內容資訊 英文 78 Pages
訂單完成後即時交付
價格
Back to Top
動脈封閉設備:醫療設備的開發平台評估 Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月18日內容資訊: 英文 78 Pages
簡介

本報告提供現在開發中的動脈封閉設備之開發中產品資訊調查分析,提供主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等相關的系統性資訊。

第1章 目錄

第2章 簡介

  • 動脈封閉設備概要

第3章 開發中的產品

  • 動脈封閉設備 - 開發中產品:各開發階段
  • 動脈封閉設備 - 開發中產品:各市場區隔
  • 動脈封閉設備 - 開發中產品:各地區
  • 動脈封閉設備 - 開發中產品:各法規途徑
  • 動脈封閉設備 - 開發中產品:各核准時期 (預定)
  • 進行中的臨床實驗

第4章 動脈封閉設備:正在開發的開發中產品 (各企業)

  • 動脈封閉設備企業 - 開發中產品:各開發階段
  • 動脈封閉設備 - 開發中產品:各開發階段

第5章 動脈封閉設備企業與產品概要

  • Aporo Biomedical, Inc. (Inactive)
  • Boston Scientific Corp
  • CardioDex Ltd.
  • CloSys Corp
  • Cook Medical Inc
  • CPC of America Inc
  • Essential Medical Inc
  • Harvard University
  • Mayo Clinic US
  • ProMed, Inc.
  • Rex Medical LP
  • Sheba Medical Center
  • Terumo Corp
  • Transluminal Technologies LLC
  • University of Rochester
  • Vascular Closure Systems, Inc.
  • Vascular Solutions Inc
  • Vivasure Medical Ltd.

第6章 動脈封閉設備:最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0876EPD

GlobalData's Medical Devices sector report, "Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Arteriotomy Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Arteriotomy Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Arteriotomy Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Arteriotomy Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Arteriotomy Closure Devices Overview 7

3 Products under Development 8

  • 3.1 Arteriotomy Closure Devices - Pipeline Products by Stage of Development 8
  • 3.2 Arteriotomy Closure Devices - Pipeline Products by Segment 9
  • 3.3 Arteriotomy Closure Devices - Pipeline Products by Territory 10
  • 3.4 Arteriotomy Closure Devices - Pipeline Products by Regulatory Path 11
  • 3.5 Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date 12
  • 3.6 Arteriotomy Closure Devices - Ongoing Clinical Trials 13

4 Arteriotomy Closure Devices - Pipeline Products under Development by Companies 14

  • 4.1 Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development 14
  • 4.2 Arteriotomy Closure Devices - Pipeline Products by Stage of Development 15

5 Arteriotomy Closure Devices Companies and Product Overview 16

  • 5.1 Aporo Biomedical, Inc. (Inactive) Company Overview 16
    • 5.1.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.2 Boston Scientific Corp Company Overview 17
    • 5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.3 CardioDex Ltd (Inactive) Company Overview 22
    • 5.3.1 CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.4 CloSys Corp Company Overview 23
    • 5.4.1 CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.5 Conformal Medical Inc Company Overview 24
    • 5.5.1 Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.6 Cor Habere Corp Company Overview 27
    • 5.6.1 Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.7 CPC of America Inc Company Overview 28
    • 5.7.1 CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.8 Dextera Surgical Inc Company Overview 29
    • 5.8.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.9 Essential Medical Inc Company Overview 30
    • 5.9.1 Essential Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.10 Harvard University Company Overview 33
    • 5.10.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.11 Mayo Clinic Company Overview 34
    • 5.11.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.12 ProMed Inc Company Overview 35
    • 5.12.1 ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.13 Rex Medical LP Company Overview 36
    • 5.13.1 Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.14 SentreHEART Inc Company Overview 38
    • 5.14.1 SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.15 Sheba Medical Center Company Overview 39
    • 5.15.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.16 Terumo Interventional Systems Company Overview 40
    • 5.16.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.17 University of Rochester Company Overview 41
    • 5.17.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.18 Vascular Closure Systems Inc Company Overview 42
    • 5.18.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.19 Vivasure Medical Ltd. Company Overview 46
    • 5.19.1 Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 46

6 Arteriotomy Closure Devices- Recent Developments 49

  • 6.1 Nov 12, 2019: Cook Medical's leadership updates in Asia-pacific reinforce focus on growth and physician relationships 49
  • 6.2 Nov 07, 2019: Cardinal Health reports first quarter results for fiscal year 2020 49
  • 6.3 Oct 30, 2019: Cardiva Medical announces publication of data From the AMBULATE pivotal study in the Journal of the American College of Cardiology: Clinical Electrophysiology 51
  • 6.4 Sep 23, 2019: Conformal Medical announces presentation of US feasibility study data at TCT 2019 in San Francisco 52
  • 6.5 Sep 18, 2019: Boston Scientific announces scheduled presentations at Transcatheter Cardiovascular Therapeutics 2019 52

7 Appendix 75

  • 7.1 Methodology 75
  • 7.2 About GlobalData 78
  • 7.3 Contact Us 78
  • 7.4 Disclaimer 78

List of Tables

  • Table 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
  • Table 2: Arteriotomy Closure Devices - Pipeline Products by Segment
  • Table 3: Arteriotomy Closure Devices - Pipeline Products by Territory
  • Table 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
  • Table 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
  • Table 6: Arteriotomy Closure Devices - Ongoing Clinical Trials
  • Table 7: Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development
  • Table 8: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
  • Table 9: Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Femoral Artery Closure Device - Product Status
  • Table 11: Femoral Artery Closure Device - Product Description
  • Table 12: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: WATCHMAN FLX - Product Status
  • Table 14: WATCHMAN FLX - Product Description
  • Table 15: Boston Scientific Corp - Ongoing Clinical Trials Overview
  • Table 16: WATCHMAN FLX - Compare Safety and Effectiveness of WATCHMAN FLX Left Atrial Appendage Closure (LAAC) and warfarin for Stroke Risk Reduction in Patients with Non-valvular Atrial Fibrillation (AF)
  • Table 17: WATCHMAN FLX - I Can See Left Atrial Appendage (ICELAA) Clinical Study
  • Table 18: WATCHMAN FLX - Protection Against Embolism for Non-valvular AF Subjects: Investigational Device Evaluation of the WATCHMAN FLX LAA Closure Technology
  • Table 19: WATCHMAN FLX - Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
  • Table 20: CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: EpiClose Plus - Product Status
  • Table 22: EpiClose Plus - Product Description
  • Table 23: CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: CloSys HD - Product Status
  • Table 25: CloSys HD - Product Description
  • Table 26: Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Left Atrial Appendage Seal - LAA Occlusion - Product Status
  • Table 28: Left Atrial Appendage Seal - LAA Occlusion - Product Description
  • Table 29: Conformal Medical Inc - Ongoing Clinical Trials Overview
  • Table 30: Left Atrial Appendage Seal - LAA Occlusion - The CONFORMAL Early Feasibility Study an Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
  • Table 31: Left Atrial Appendage Seal - LAA Occlusion - The Conformal Prague Study: An Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
  • Table 32: Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: StrokeShield System - Product Status
  • Table 34: StrokeShield System - Product Description
  • Table 35: CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: MedClose - Product Status
  • Table 37: MedClose - Product Description
  • Table 38: Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: X-Port Vascular Access Closure Device - Product Status
  • Table 40: X-Port Vascular Access Closure Device - Product Description
  • Table 41: Essential Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: MANTA - Product Status
  • Table 43: MANTA - Product Description
  • Table 44: Essential Medical Inc - Ongoing Clinical Trials Overview
  • Table 45: MANTA - MANTA Versus Suture-based Closure after Transcatheter Aortic Valve Implantation Trial
  • Table 46: MANTA - Post-market Clinical Registry to Evaluate the Safety and Performance of MANTA Vascular Closure Device (VCD) Under Real World Conditions in the European Union (EU)
  • Table 47: Harvard University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Access-Closure Device - Product Status
  • Table 49: Access-Closure Device - Product Description
  • Table 50: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Left Atrial Appendage Closure Device - Product Status
  • Table 52: Left Atrial Appendage Closure Device - Product Description
  • Table 53: ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Large Hole Closure Device - Product Status
  • Table 55: Large Hole Closure Device - Product Description
  • Table 56: Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Auto-Close Vascular Sealing System - Product Status
  • Table 58: Auto-Close Vascular Sealing System - Product Description
  • Table 59: Large Bore Closer Vascular Sealing System - Product Status
  • Table 60: Large Bore Closer Vascular Sealing System - Product Description
  • Table 61: SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Eclipse Surgical Left Atrial Appendage Closure Device - Product Status
  • Table 63: Eclipse Surgical Left Atrial Appendage Closure Device - Product Description
  • Table 64: Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Status
  • Table 66: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Description
  • Table 67: Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: Vascular Closure Device - Product Status

List of Figures

  • Figure 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
  • Figure 2: Arteriotomy Closure Devices - Pipeline Products by Segment
  • Figure 3: Arteriotomy Closure Devices - Pipeline Products by Territory
  • Figure 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
  • Figure 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
  • Figure 6: Arteriotomy Closure Devices - Ongoing Clinical Trials
Back to Top